National guidelines for the prevention and control of diabetes in primary care (2022)

Abstract

The prevalence of diabetes in China has increased significantly, and about 11.9% of adults have diabetes. According to the report on chronic disease risk factor surveillance in China 2018, the rates of awareness, treatment and glycemic control of diabetes in China were only 38.0%, 34.1% and 33.1%, respectively. There are rigorous challenges existing in terms of diabetes prevention and glycemic control, especially in primary medical care. Under the guidance of National Health Commission of the People's Republic of China and Chinese Medical Association, National Office for Primary Diabetes Care issued the "National guidelines for the prevention and control of diabetes in primary care (2018)" in 2018. To improve the ability of primary health facilities and provide standardized basic public health and medical services throughout the country, the present guideline is released with updating the latest progresses in diabetes research and practice based on the 2018 edition. It is applicable to healthcare providers in primary care for type 2 diabetic patients over 18 years of age, and includes basic requirements for management, workflow of health management, diagnosis, treatment, identification and management of diabetic acute complications and chronic complications, traditional Chinese medicine, referral, and health management.